14 assets in Hairy Cell Leukemia

Therapeutic assets addressing Hairy Cell Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cyclophosphamide Hairy Cell Leukemia	Kite, A Gilead Company	P2	BB (70)
Fludarabine Hairy Cell Leukemia	Kite, A Gilead Company	P2	B (62)
Etoposide Hairy Cell Leukemia	City of Hope Medical Center	P1/2	B (57)
Brexucabtagene Autoleucel Hairy Cell Leukemia	Kite, A Gilead Company	P2	CCC (53)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes Hairy Cell Leukemia	City of Hope Medical Center	P1	CC (43)
Bendamustine Hairy Cell Leukemia	City of Hope Medical Center	P1	CC (43)
cd22 car-t Hairy Cell Leukemia	Stanford University	P1	CC (43)
lp-168 Hairy Cell Leukemia	Newave Pharmaceutical Inc	P1	CC (43)
mgd024 Hairy Cell Leukemia	MacroGenics	P1	CC (43)